000 01609 a2200445 4500
005 20250513230743.0
264 0 _c20010405
008 200104s 0 0 eng d
022 _a0011-9059
024 7 _a10.1046/j.1365-4362.2000.00988-3.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYamazaki, M
245 0 0 _aNasal natural killer cell lymphoma presenting as lethal midline granuloma.
_h[electronic resource]
260 _bInternational journal of dermatology
_cDec 2000
300 _a931-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCyclophosphamide
_xtherapeutic use
650 0 4 _aDNA Primers
_xchemistry
650 0 4 _aDNA, Neoplasm
_xanalysis
650 0 4 _aDiagnosis, Differential
650 0 4 _aDoxorubicin
_xtherapeutic use
650 0 4 _aGranuloma, Lethal Midline
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aKiller Cells, Natural
_xchemistry
650 0 4 _aLymphoma, T-Cell
_xchemistry
650 0 4 _aMale
650 0 4 _aParanasal Sinus Neoplasms
_xchemistry
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aVincristine
_xtherapeutic use
700 1 _aKakuta, M
700 1 _aTakimoto, R
700 1 _aMurayama, N
700 1 _aTakamori, K
773 0 _tInternational journal of dermatology
_gvol. 39
_gno. 12
_gp. 931-4
856 4 0 _uhttps://doi.org/10.1046/j.1365-4362.2000.00988-3.x
_zAvailable from publisher's website
999 _c11107651
_d11107651